
    
      This clinical trial examines the effectiveness of a treatment comparing it to another known
      treatment.

      The U.S. Food and Drug Administration (FDA) has approved the navigation bronchoscopy as a
      treatment option for this disease.

      The U.S. Food and Drug Administration (FDA) has approved the Cone-Beam CT scan as a treatment
      option for this disease.

      This research study involves a screening period, a procedure and follow up visits.

      The names of the study interventions involved in this study are:

        -  Computed tomography (CBCT)-guided navigation bronchoscopy (CBCT-guided NB)

        -  Navigation bronchoscopy alone

      Participants will receive the study procedure and will be followed for up to 6 months.

      It is expected that about 136 people will take part in this research study.
    
  